TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11514369

Group type: EXPERIMENTAL
Intervention: Intravenous gamma globulin therapy
Number of subjects: 65

Group type: COMPARATOR
Intervention: Febrile disease controls
Number of subjects: 65
Study: 9700472

Group type: EXPERIMENTAL
Intervention: Alendronate 2.5 mg/day (L)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Alendronate 10 mg/day (H)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 113
Study: 8077368

Group type: EXPERIMENTAL
Intervention: beta-endorphin (0.5 mg/h)
Number of subjects: 16

Group type: COMPARATOR
Intervention: naloxone (5 mg in 5 min)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: beta-endorphin and naloxone
Number of subjects: 16
Study: 2807803

Group type: EXPERIMENTAL
Intervention: GE 300/15/80 degrees
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: GE 300/15/64 degrees
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: SE 250/20
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: SE 500/30
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: SE 900/30
Number of subjects: 27
Study: 8184

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 30773731

Group type: EXPERIMENTAL
Intervention: Gabapentin 300 mg three times a day orally for 2 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 40
Study: 28833521

Group type: EXPERIMENTAL
Intervention: Peer support group intervention (8 weekly sessions of 1.5 hours each)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Peer support group intervention
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 80
Study: 25845941

Group type: EXPERIMENTAL
Intervention: In-line filtration (filter group)
Number of subjects: 305

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 305
Study: 23219787

Group type: EXPERIMENTAL
Intervention: Gait Report group (N = 83)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Control group (N = 73)
Number of subjects: 156
Study: 20309015

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 182

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 182
Study: 19175852

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Control group (nonresponders)
Number of subjects: 198
Study: 16772442

Group type: EXPERIMENTAL
Intervention: Dual fortified salt (DFS) with 3 mg Fe/g salt as ground FePP
Number of subjects: 123

Group type: COMPARATOR
Intervention: Iodized salt (IS)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 123
Study: 15390350

Group type: EXPERIMENTAL
Intervention: Dornase alpha
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 11520368

Group type: EXPERIMENTAL
Intervention: Weekly regimen (paclitaxel 60 mg/m2, carboplatin AUC 2)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Monthly regimen (paclitaxel 175 mg/m2, carboplatin AUC 6)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Weekly regimen
Number of subjects: 29

Group type: COMPARATOR
Intervention: Monthly regimen
Number of subjects: 29
Study: 9777130

Group type: EXPERIMENTAL
Intervention: Reteplase administration
Number of subjects: 15000

Group type: COMPARATOR
Intervention: Front-loaded alteplase regimen
Number of subjects: 15000

Group type: COMPARATOR
Intervention: Double bolus alteplase administration
Number of subjects: 15000

Group type: COMPARATOR
Intervention: COBALT trial (control group)
Number of subjects: 15000
Study: 7890014

Group type: EXPERIMENTAL
Intervention: Probucol (500 mg bd)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Vitamin E (400 IU daily)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 3418579

Group type: EXPERIMENTAL
Intervention: Nasogastric tube present
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postoperative sputum culture
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postoperative radiographic changes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no nasogastric tube)
Number of subjects: 0
Study: 29320591

Group type: EXPERIMENTAL
Intervention: Moisturizer with 7% sweet almond oil and 2% colloidal oatmeal
Number of subjects: 0
Study: 27230863

Group type: EXPERIMENTAL
Intervention: 12-week Internet intervention (Deprexis) adjunctive to usual care
Number of subjects: 1013

Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 1013
Study: 25017534

Group type: EXPERIMENTAL
Intervention: Real-time outreach intervention including letter notification and electronic message to physician
Number of subjects: 1999

Group type: EXPERIMENTAL
Intervention: Real-time outreach intervention
Number of subjects: 1999

Group type: COMPARATOR
Intervention: Control group (standard asthma care management)
Number of subjects: 1999
Study: 23189301

Group type: EXPERIMENTAL
Intervention: Submerged dental implants in organ transplant patients
Number of subjects: 20

Group type: COMPARATOR
Intervention: Submerged dental implants in control patients
Number of subjects: 20
Study: 22009948

Group type: EXPERIMENTAL
Intervention: Modified Minimally Invasive Approach (MMIA)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Traditional Operative Approach (TOPA)
Number of subjects: 91
Study: 18176645

Group type: EXPERIMENTAL
Intervention: Copal varnish (CV)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Duraphat
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Gluma Comfort Bond Plus Desensitizer
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: 2% fluoride iontophoresis
Number of subjects: 116
Study: 15729523

Group type: EXPERIMENTAL
Intervention: Bilateral STN stimulation
Number of subjects: 34

Group type: COMPARATOR
Intervention: Unilateral pallidotomy
Number of subjects: 34
Study: 12883589

Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ranitidine 600 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Olanzapine without Ranitidine
Number of subjects: 0
Study: 10931390

Group type: EXPERIMENTAL
Intervention: G-CSF treatment combined with HAART
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9298163

Group type: EXPERIMENTAL
Intervention: 10% xylitol in enzyme-containing dentifrice
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 5% xylitol in enzyme-containing dentifrice
Number of subjects: 50
Study: 8314646

Group type: EXPERIMENTAL
Intervention: High risk exercise response
Number of subjects: 855

Group type: COMPARATOR
Intervention: Low risk exercise response
Number of subjects: 855

Group type: EXPERIMENTAL
Intervention: Indicators of ST-depression, occurrence of angina, and low peak load at exercise
Number of subjects: 855
Study: 2942599

Group type: EXPERIMENTAL
Intervention: 10 micrograms of HB‐VAX vaccine
Number of subjects: 605

Group type: COMPARATOR
Intervention: 20 micrograms of HB‐VAX vaccine
Number of subjects: 605
Study: 31705154

Group type: EXPERIMENTAL
Intervention: Endovascular therapy (EVT) under current local resources
Number of subjects: 607

Group type: EXPERIMENTAL
Intervention: Endovascular therapy (EVT) under assumed ideal conditions
Number of subjects: 607
Study: 29555019

Group type: EXPERIMENTAL
Intervention: Placebo treatment with precise treatment expectations
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Placebo treatment
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Neural correlates observed in the periaqueductal gray and rostral ventromedial medulla
Number of subjects: 62
Study: 27211225

Group type: EXPERIMENTAL
Intervention: Motivational interviewing-based counseling intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non-standardized counseling
Number of subjects: 60
Study: 26537136

Group type: EXPERIMENTAL
Intervention: Hernioplasty with mesh (Lichtenstein technique)
Number of subjects: 263

Group type: COMPARATOR
Intervention: Hernioplasty without mesh (Bassini technique)
Number of subjects: 263
Study: 23771450

Group type: EXPERIMENTAL
Intervention: Adherence counseling and twice weekly short message reminders for four months
Number of subjects: 104

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 104
Study: 19830412

Group type: EXPERIMENTAL
Intervention: Continuous visual feedback (CF) during task execution
Number of subjects: 0

Group type: COMPARATOR
Intervention: Post-trial visual feedback (PF)
Number of subjects: 0
Study: 18815991

Group type: EXPERIMENTAL
Intervention: Written emotional disclosure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Writing control
Number of subjects: 0
Study: 16650482

Group type: EXPERIMENTAL
Intervention: Young Schema Questionnaire-Short Form (YSQ-SF)
Number of subjects: 1104
Study: 12862331

Group type: EXPERIMENTAL
Intervention: Exercise-heat acclimation (HA); 90 min x d(‐1), 40 degrees C for 7 days
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 17
Study: 11034942

Group type: EXPERIMENTAL
Intervention: BQ‐123 (6 micromol/L over 20 minutes)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: BQ‐123
Number of subjects: 80
Study: 8607953

Group type: EXPERIMENTAL
Intervention: Dexamethasone sodium phosphate
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 30610380

Group type: EXPERIMENTAL
Intervention: Slow cortical potential neurofeedback (SCP-NF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Electromyogram biofeedback (EMG-BF)
Number of subjects: 0
Study: 30587219

Group type: EXPERIMENTAL
Intervention: vixotrigine
Number of subjects: 125

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 125
Study: 27333019

Group type: EXPERIMENTAL
Intervention: Zirconia abutment
Number of subjects: 24

Group type: COMPARATOR
Intervention: Titanium abutment
Number of subjects: 24
Study: 24268369

Group type: EXPERIMENTAL
Intervention: Caloric restriction (CR: 25% reduction in energy intake, n=12)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Caloric restriction + exercise (CR+EX: 12.5% reduction in energy intake + 12.5% increase in exercise energy expenditure, n=12)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control (healthy weight-maintenance diet, n=11)
Number of subjects: 35
Study: 22850688

Group type: EXPERIMENTAL
Intervention: Slow release oxcarbazepine (OXC‐MR)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Immediate release oxcarbazepine (OXC‐IR)
Number of subjects: 71
Study: 18349194

Group type: EXPERIMENTAL
Intervention: Infusion of liquid sevoflurane to achieve a target end-tidal concentration of 1%
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Infusion of liquid sevoflurane to achieve a target end-tidal concentration of 1.5%
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Infusion scheme to increase target concentration by 0.3%
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Infusion scheme to decrease target concentration by 0.3%
Number of subjects: 50
Study: 17152332

Group type: EXPERIMENTAL
Intervention: Nurse practitioner
Number of subjects: 200

Group type: COMPARATOR
Intervention: Resident
Number of subjects: 200
Study: 14640465

Group type: EXPERIMENTAL
Intervention: Simvastatin (20-80 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Atorvastatin (10-80 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 0
Study: 10847577

Group type: EXPERIMENTAL
Intervention: Bioptic telescopes and training
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Training with telescopic lenses
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Driving-related skills training
Number of subjects: 25

Group type: COMPARATOR
Intervention: Telescopic lenses without training
Number of subjects: 25
Study: 9413107

Group type: EXPERIMENTAL
Intervention: Two primary doses of DTaP
Number of subjects: 0

Group type: COMPARATOR
Intervention: Three primary doses of DTaP
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two primary doses of DTaP followed by a booster
Number of subjects: 0

Group type: COMPARATOR
Intervention: Three primary doses of DTaP followed by a booster
Number of subjects: 0
Study: 8383638

Group type: EXPERIMENTAL
Intervention: Dexfenfluramine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 3758146

Group type: EXPERIMENTAL
Intervention: DHE 1 mg intranasally
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: DHE 0.5 mg intramuscularly
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (intranasally and i.m.)
Number of subjects: 9
Study: 28722271

Group type: EXPERIMENTAL
Intervention: Liraglutide (0.6 to 1.8 mg over 24 weeks)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (saline solution)
Number of subjects: 15
Study: 27535438

Group type: EXPERIMENTAL
Intervention: Cemented fixation
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Hybrid fixation
Number of subjects: 32
Study: 25014996

Group type: EXPERIMENTAL
Intervention: Xuan Bai Cheng Qi formula
Number of subjects: 244

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 244
Study: 21256606

Group type: COMPARATOR
Intervention: Control saline (n=55)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Adenosine 50 μg (n=54)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Nicorandil 4 mg (n=54)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Adenosine-nicorandil combination (n=50)
Number of subjects: 213
Study: 20392970

Group type: EXPERIMENTAL
Intervention: PLLA interference screws
Number of subjects: 77

Group type: COMPARATOR
Intervention: Metal interference screws
Number of subjects: 77
Study: 18721643

Group type: EXPERIMENTAL
Intervention: Dysphoria
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Marital discord
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Criticality bias
Number of subjects: 72
Study: 16567820

Group type: EXPERIMENTAL
Intervention: CCM intervention
Number of subjects: 119
Study: 14531555

Group type: EXPERIMENTAL
Intervention: 5-aminolevulinic acid (5-ALA) administration for fluorescence-guided resections
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 11041588

Group type: EXPERIMENTAL
Intervention: Unicompartmental knee replacement (UKR)
Number of subjects: 43
Study: 8613538

Group type: EXPERIMENTAL
Intervention: DHA-rich oil capsules (1.5-1.8 grams DHA/day)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control oil capsules (97% soybean oil + 3% fish oil)
Number of subjects: 41
Study: 1486515

Group type: EXPERIMENTAL
Intervention: Personal safety program taught by parents
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Personal safety program taught by teachers
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Personal safety program taught by both teachers and parents
Number of subjects: 172

Group type: COMPARATOR
Intervention: General safety control program
Number of subjects: 172
Study: 3882681

Group type: EXPERIMENTAL
Intervention: Fluoxetine 30 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Fluoxetine 60 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Fluoxetine 75 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 31995223

Group type: EXPERIMENTAL
Intervention: Vocational rehabilitation
Number of subjects: 46
Study: 29368635

Group type: EXPERIMENTAL
Intervention: Strict glycaemic control (4-7 mmol/L; 72-126 mg/dl)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional glycaemic control (<10 mmol/L; 180 mg/dl)
Number of subjects: 20
Study: 27031544

Group type: EXPERIMENTAL
Intervention: Extracorporeal Shockwave Therapy (ESWT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham stimulation (Control)
Number of subjects: 0
Study: 26525102

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation for 6 weeks
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: SNPs in PLA2G4A and PLA2G6 genes
Number of subjects: 191
Study: 23674289

Group type: EXPERIMENTAL
Intervention: 6-minute walk test (6MWT)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: 6-minute walk distance (6MWD)
Number of subjects: 174
Study: 19944453

Group type: EXPERIMENTAL
Intervention: Vaginal brachytherapy (VB) alone
Number of subjects: 87
Study: 18413554

Group type: EXPERIMENTAL
Intervention: Simvastatin, 20 mg
Number of subjects: 973

Group type: EXPERIMENTAL
Intervention: Pravastatin, 40 mg
Number of subjects: 973

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 973
Study: 16792171

Group type: EXPERIMENTAL
Intervention: Cutting forceps
Number of subjects: 100

Group type: COMPARATOR
Intervention: Non-cutting forceps
Number of subjects: 100
Study: 15189665

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 401

Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 401
Study: 10601051

Group type: EXPERIMENTAL
Intervention: Intraduodenal long chain triglyceride (LCT) infusion
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Intraduodenal medium chain triglyceride (MCT) infusion
Number of subjects: 9

Group type: COMPARATOR
Intervention: Saline infusion (control)
Number of subjects: 9
Study: 9175688

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 186

Group type: COMPARATOR
Intervention: Laparotomy
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Preoperative workup and diagnostic laparoscopy
Number of subjects: 186
Study: 1550081

Group type: EXPERIMENTAL
Intervention: Late intensification chemotherapy
Number of subjects: 192

Group type: COMPARATOR
Intervention: Standard maintenance therapy
Number of subjects: 192
Study: 3516395

Group type: EXPERIMENTAL
Intervention: High-dose cytarabine (3 g/m2 every 12 hours for 6 days)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Amsacrine (75 mg/m2 daily for 7 days)
Number of subjects: 48
Study: 30252548

Group type: EXPERIMENTAL
Intervention: Suction blistering technique
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Mini punch technique
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Hair follicle technique
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: All techniques (suction blistering, mini punch, hair follicle)
Number of subjects: 30
Study: 27357833

Group type: EXPERIMENTAL
Intervention: Twitter
Number of subjects: 494

Group type: COMPARATOR
Intervention: Facebook
Number of subjects: 494
Study: 25448996

Group type: EXPERIMENTAL
Intervention: Baseline Heidelberg Retina Tomograph (HRT) parameters
Number of subjects: 489
Study: 23567070

Group type: EXPERIMENTAL
Intervention: Paricalcitol treatment
Number of subjects: 52

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 52
Study: 21174107

Group type: EXPERIMENTAL
Intervention: Laparoscopic-assisted surgery (LS)
Number of subjects: 1033
Study: 19210140

Group type: EXPERIMENTAL
Intervention: BIAsp 30 BID
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: BIAsp 30 QD
Number of subjects: 372

Group type: COMPARATOR
Intervention: Exenatide
Number of subjects: 372
Study: 16887443

Group type: EXPERIMENTAL
Intervention: Prednisone (1 mg/kg/day for 2 weeks, with weaning over the subsequent 2 weeks)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 171
Study: 15534844

Group type: EXPERIMENTAL
Intervention: Prehospital ST monitoring with synthesized 12-lead ECG and telephone transmission to the target hospital.
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control group using only ECGs recorded after hospital arrival.
Number of subjects: 5
Study: 11705719

Group type: EXPERIMENTAL
Intervention: Schizophrenia patients
Number of subjects: 22

Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 22
Study: 9024171

Group type: EXPERIMENTAL
Intervention: Acetaminophen coadministered with isoniazid (8 am dose)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Acetaminophen given 12 hours after isoniazid dose
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Acetaminophen with isoniazid for fast acetylators
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Acetaminophen with isoniazid for slow acetylators
Number of subjects: 10
Study: 8155010

Group type: EXPERIMENTAL
Intervention: Aspirin (30 or 283 mg/d)
Number of subjects: 3021

Group type: EXPERIMENTAL
Intervention: History and electrocardiogram assessment
Number of subjects: 3021
Study: 3351376

Group type: EXPERIMENTAL
Intervention: Portable lap computer (PLC)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Conventional ward terminals
Number of subjects: 12
Study: 31362299

Group type: COMPARATOR
Intervention: High-Flux Hemodialysis (HF-HD)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Online Hemodiafiltration (olHDF)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: High-Retention-Onset Hemodialysis (HRO-HD)
Number of subjects: 16
Study: 30282670

Group type: EXPERIMENTAL
Intervention: Etanercept (50 mg/week for 24 weeks, then 25 mg/week)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 27027523

Group type: EXPERIMENTAL
Intervention: Ranibizumab (IVR)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Aflibercept (IVA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 60
Study: 24716478

Group type: EXPERIMENTAL
Intervention: 16-week IPV prevention intervention using a men's discussion group format
Number of subjects: 12
Study: 24164001

Group type: EXPERIMENTAL
Intervention: Empowerment program based on Gibson's model (weeks 1, 4, and 8)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 60
Study: 21940397

Group type: COMPARATOR
Intervention: McGrath laryngoscope
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: APA with Difficult Airway Blade (DAB)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: APA with DAB
Number of subjects: 48
Study: 18196524

Group type: EXPERIMENTAL
Intervention: 40 mg simvastatin (SV) tablet formulation
Number of subjects: 12
Study: 17075122

Group type: EXPERIMENTAL
Intervention: Bortezomib 1.5 mg/m2 (arm A)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Bortezomib 1.3 mg/m2 plus docetaxel 75 mg/m2 (arm B)
Number of subjects: 155
Study: 14504681

Group type: EXPERIMENTAL
Intervention: Lithium carbonate
Number of subjects: 0
Study: 10955391

Group type: EXPERIMENTAL
Intervention: Cyclosporine A
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tacrolimus (FK 506)
Number of subjects: 0